B

Bright Minds Biosciences Inc
CNSX:DRUG

Watchlist Manager
Bright Minds Biosciences Inc
CNSX:DRUG
Watchlist
Price: 59 CAD 4.8% Market Closed
Market Cap: 263.4m CAD
Have any thoughts about
Bright Minds Biosciences Inc?
Write Note

Bright Minds Biosciences Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bright Minds Biosciences Inc
Cash from Operating Activities Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
B
Bright Minds Biosciences Inc
CNSX:DRUG
Cash from Operating Activities
-CA$7m
CAGR 3-Years
-190%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cash from Operating Activities
-$1.5m
CAGR 3-Years
54%
CAGR 5-Years
N/A
CAGR 10-Years
14%
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Operating Activities
-$127.2m
CAGR 3-Years
-176%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Operating Activities
-$1.7m
CAGR 3-Years
76%
CAGR 5-Years
49%
CAGR 10-Years
19%
Covalon Technologies Ltd
XTSX:COV
Cash from Operating Activities
CA$1.2m
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
-9%
Spectral Medical Inc
TSX:EDT
Cash from Operating Activities
-CA$8.5m
CAGR 3-Years
-2%
CAGR 5-Years
-42%
CAGR 10-Years
1%

See Also

What is Bright Minds Biosciences Inc's Cash from Operating Activities?
Cash from Operating Activities
-7m CAD

Based on the financial report for Sep 30, 2023, Bright Minds Biosciences Inc's Cash from Operating Activities amounts to -7m CAD.

What is Bright Minds Biosciences Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-190%

Over the last year, the Cash from Operating Activities growth was 48%. The average annual Cash from Operating Activities growth rates for Bright Minds Biosciences Inc have been -190% over the past three years .

Back to Top